Home / Stocks / Metropolis Healthcare Ltd
METROPOLIS

Metropolis Healthcare Ltd Share Price

Live price, chart and which mutual funds hold this stock

…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 19 Nov 2026

₹558.7

Change

-5.6 (-0.99%)

Open

₹567.1

Prev. Close

₹564.3

Day High

₹574.95

Day Low

₹556.85

Volume Analysis

Traded

179,988

Delivered

100,051

Delivery %

55.59%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (1)

  • •Strong operating margin (25.0%)

Weaknesses (1)

  • •Promoter holding is falling

Opportunities (0)

No signal for this stock

Threats (1)

  • •FII holding has been falling

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹588.25 ₹581.6 ₹570.15 ₹563.5 ₹552.05 ₹545.4 ₹533.95
Fibonacci ₹581.6 ₹574.69 ₹570.41 ₹563.5 ₹556.59 ₹552.31 ₹545.4
Camarilla ₹563.68 ₹562.02 ₹560.36 ₹563.5 ₹557.04 ₹555.38 ₹553.72

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

-70.55%

1 Week

-1.15%

1 Month

+4.7%

3 Months

+0.31%

6 Months

+7.66%

1 Year

-71.49%

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

Graham Number

₹127.75

Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.

DuPont ROE Breakdown

12.66%

Net margin 12.65% × asset turnover 0.7x × equity multiplier 1.43x

Company Overview

Sector

Healthcare

Market Cap

₹11,711 Cr

P/E (TTM)

50.7

ROE

13.6%

Book Value

₹79.1

Face Value

₹2.0

Source: Screener.in (Consolidated figures) — data as of 19 Nov 2026. Not investment advice.

TopFund Analysis

Metropolis Healthcare Ltd lands in the middle of the pack on TopFund's composite fundamentals check within the Healthcare sector, at 64/100. The strongest factor is Financial Strength (100/100), while Valuation (7/100) is the weakest area to weigh before deciding. Notably: Strong operating margin (25.0%); promoter holding is falling. FII holding has been falling.

TopFund Score — Fundamentals Quality

64/100 — Average

Data confidence: 80/100 (High Confidence) — based on how complete and how fresh the underlying data is.

As of 19 Nov 2026 · How we calculate this →

Financial Strength

100

Growth

41

Valuation

7

Cash Flow

99

Corporate Governance

72

Momentum

77

Institutional Ownership

64

Business Quality

77

Risk & Volatility

25

Liquidity

60

From Screener.in

  • −Stock is trading at 7.13 times its book value
  • −Promoter holding has decreased over last quarter: -1.04%
  • −The company has delivered a poor sales growth of 10.5% over past five years.
  • −Company has a low return on equity of 12.5% over last 3 years.

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

Transcript of Q2 and H1 FY27 earnings conference call held on November 04, 2026

Metropolis Healthcare schedules analyst and institutional investor meeting with Avendus Spark on November 16, 2026.

Audio recording of Q2 FY27 earnings conference call available on November 4, 2026.

Metropolis Healthcare reported Q2 FY27 revenue of ₹497 crore, PAT of ₹75 crore, and declared ₹1 interim dividend.

Source: BSE regulatory filings, via Screener.in.

Quarterly Results

Last several quarters

  Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Sales + 308 291 331 313 350 323 345 386 429 406 425 450 497
Expenses + 234 226 251 235 260 251 283 296 321 311 317 339 363
Operating Profit 75 65 80 79 90 72 62 90 108 95 108 111 134
OPM % 24.0% 22.0% 24.0% 25.0% 26.0% 22.0% 18.0% 23.0% 25.0% 23.0% 25.0% 25.0% 27.0%
Other Income + 1 2 3 2 3 3 7 8 1 0 8 5 8
Interest 6 5 6 5 5 5 5 5 6 6 8 6 7
Depreciation 22 25 26 26 27 28 29 31 32 32 39 32 33
Profit before tax 48 37 51 51 61 42 36 61 71 57 70 78 102
Tax % 26.0% 26.0% 28.0% 25.0% 24.0% 26.0% 19.0% 26.0% 26.0% 26.0% 27.0% 27.0% 26.0%
Net Profit + 36 27 37 38 47 31 29 45 53 42 51 57 75
EPS in Rs 2 1 2 2 2 2 1 2 3 2 2 3 4
Raw PDF — — — — — — — — — — — — —
YoY Sales growth 3 2 17 13 13 11 4 23 23 26 23 17 16

Source: Screener.in — figures in ₹ Crores unless marked %.

Profit & Loss (Yearly)

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Sales + 456 475 545 647 761 856 998 1,228 1,148 1,208 1,331 1,646 1,778
Expenses + 339 359 405 467 559 619 708 880 855 920 1,023 1,240 1,330
Operating Profit 117 116 140 181 203 237 290 348 293 288 308 406 448
OPM % 26.0% 24.0% 26.0% 28.0% 27.0% 28.0% 29.0% 28.0% 26.0% 24.0% 23.0% 25.0% 25.0%
Other Income + 7 29 39 6 8 -17 12 34 15 9 15 16 22
Interest 2 2 2 4 4 13 12 25 32 28 24 29 27
Depreciation 21 17 17 19 20 39 46 63 89 94 109 134 136
Profit before tax 101 128 160 164 187 169 244 293 188 175 191 259 307
Tax % 33.0% 36.0% 33.0% 32.0% 34.0% 24.0% 25.0% 27.0% 24.0% 26.0% 24.0% 26.0% —
Net Profit + 68 82 107 112 124 128 183 215 143 128 146 191 225
EPS in Rs 3 4 5 5 6 6 9 10 7 6 7 9 11
Dividend Payout % 0.0% 100.0% 49.0% 0.0% 55.0% 32.0% 22.0% 19.0% 29.0% 16.0% 0.0% 55.0% —
Sales growth 17 4 15 19 18 13 17 23 -7 5 10 24 20

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Sep 2026
Reserves 352 269 314 405 408 513 696 876 978 1,086 1,321 1,472 1,600
Borrowings + 14 5 1 1 18 67 112 379 266 197 204 232 268
Other Liabilities + 87 107 188 110 113 160 181 256 240 254 324 386 431
Total Liabilities 462 391 512 526 550 750 1,000 1,521 1,495 1,547 1,859 2,131 2,341
Fixed Assets + 153 142 202 207 213 296 343 1,059 1,121 1,177 1,447 1,601 1,637
CWIP 0 1 1 0 6 3 0 6 20 0 0 0 0
Investments 168 101 142 102 33 14 10 16 15 55 71 142 271
Other Assets + 141 147 167 216 298 437 647 440 340 316 341 387 433
Total Assets 462 391 512 526 550 750 1,000 1,521 1,495 1,547 1,859 2,131 2,341
Equity Capital 10 10 10 10 10 10 10 10 10 10 10 41 41

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Cash from Operating Activity + 69 91 102 104 90 215 249 253 247 264 263 351
Cash from Investing Activity + -56 96 -86 1 36 -104 63 -736 48 -89 -199 -220
Cash from Financing Activity + -9 -174 -17 -87 -118 -55 -33 163 -292 -181 -87 -115
Net Cash Flow 4 14 -1 18 8 56 279 -321 3 -6 -23 15
Free Cash Flow 46 79 45 90 67 179 221 223 195 200 196 300
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 87 113 109 89 78 118 106 96 102 105 99 98

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 49.74% → 47.82%
  Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Public 7.87% 6.57% 4.69% 3.98% 3.86% 5.51% 5.87% 5.48% 4.69% 4.92% 5.0% 5.02%
Promoters 49.74% 49.67% 49.62% 49.43% 49.4% 48.89% 48.89% 48.89% 48.87% 48.86% 48.86% 47.82%
FII 21.66% 18.9% 18.25% 18.56% 16.73% 15.29% 12.83% 12.52% 11.68% 10.43% 11.03% 11.67%
DII 20.73% 24.86% 27.42% 28.02% 30.0% 30.3% 32.4% 33.1% 34.73% 35.8% 35.12% 35.49%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Healthcare — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Metropolis Healthcare Ltd (this stock) 11,711 50.7 7.13 13.6%
Viyash Scientific Limited 11,285 46.6 3.56 7.39%
Akums Drugs And Pharma L 11,279 29.9 3.22 8.45%
Concord Biotech Limited 12,146 42.6 5.86 12.9%
Park Medi World Limited 11,039 43.1 5.12 16.8%
Rainbow Childrens Med Ltd 12,607 43.0 7.34 16.7%
Symbiotec Pharmalab Ltd 10,354 70.0 7.6 11.7%

Which Mutual Funds Hold Metropolis Healthcare Ltd?

Frequently Asked Questions about Metropolis Healthcare Ltd

Community Sentiment

What are other investors saying about Metropolis Healthcare Ltd?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.